ENTX MEXC RealStocks
Own real ENTX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 01:52:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Entera Bio Ltd. (ENTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3.22, with a market capitalization of $563.51M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.91 to $4.20. This page covers its latest market performance, valuation, price trends and company information.
$563.51M | |
$3.20 | |
$3.23 | |
$3.12 | |
$3.22 | |
139.55K | |
454.03K | |
-- | |
$4.20 | |
$0.91 | |
-- | |
-- |
Entera Bio Ltd. (ENTX) last closed at $3.22 as of 2026-11-12 23:58:00, down 0.16% ($0.01) from the previous close of $3.22.
During the latest regular trading session, ENTX traded between $3.12 and $3.23, with a volume of 139.55K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Entera Bio Ltd. (ENTX) moved from $3.05 to $3.22, representing a gain of 5.70% ($0.17).
The stock traded between $2.90 and $3.49 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 211.49 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 70.3%
ENTX is currently trading at $3.22, placing it 70.3% of the way from its 52-week low of $0.91 to its 52-week high of $4.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 22 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Entera Bio Ltd.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Entera Bio Ltd. (ENTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ENTX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ENTX shares and USD.
ENTX Shares to USD
1.00 ENTX shares = 3.224 USD
Calculations are estimates based on the latest available price and are for reference only.